GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Probi AB (OSTO:PROB) » Definitions » Cyclically Adjusted PB Ratio

Probi AB (OSTO:PROB) Cyclically Adjusted PB Ratio : 2.18 (As of Apr. 29, 2024)


View and export this data going back to 1998. Start your Free Trial

What is Probi AB Cyclically Adjusted PB Ratio?

As of today (2024-04-29), Probi AB's current share price is kr209.00. Probi AB's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 was kr95.77. Probi AB's Cyclically Adjusted PB Ratio for today is 2.18.

The historical rank and industry rank for Probi AB's Cyclically Adjusted PB Ratio or its related term are showing as below:

OSTO:PROB' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 2.08   Med: 6.46   Max: 16.02
Current: 2.18

During the past years, Probi AB's highest Cyclically Adjusted PB Ratio was 16.02. The lowest was 2.08. And the median was 6.46.

OSTO:PROB's Cyclically Adjusted PB Ratio is ranked worse than
57.14% of 651 companies
in the Drug Manufacturers industry
Industry Median: 1.76 vs OSTO:PROB: 2.18

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Probi AB's adjusted book value per share data for the three months ended in Mar. 2024 was kr125.164. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is kr95.77 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Probi AB Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Probi AB's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Probi AB Cyclically Adjusted PB Ratio Chart

Probi AB Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5.29 8.59 6.56 2.57 2.18

Probi AB Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.11 2.09 2.14 2.18 2.20

Competitive Comparison of Probi AB's Cyclically Adjusted PB Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Probi AB's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Probi AB's Cyclically Adjusted PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Probi AB's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Probi AB's Cyclically Adjusted PB Ratio falls into.



Probi AB Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Probi AB's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=209.00/95.77
=2.18

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Probi AB's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Probi AB's adjusted Book Value per Share data for the three months ended in Mar. 2024 was:

Adj_Book=Book Value per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=125.164/130.9575*130.9575
=125.164

Current CPI (Mar. 2024) = 130.9575.

Probi AB Quarterly Data

Book Value per Share CPI Adj_Book
201406 13.822 100.432 18.023
201409 14.551 100.161 19.025
201412 15.107 100.225 19.739
201503 17.422 99.950 22.827
201506 17.738 99.995 23.230
201509 19.098 100.228 24.953
201512 19.380 100.276 25.310
201603 22.168 100.751 28.814
201606 22.990 101.019 29.803
201609 25.905 101.138 33.543
201612 78.292 102.022 100.498
201703 82.365 102.022 105.726
201706 78.590 102.752 100.163
201709 76.709 103.279 97.267
201712 77.649 103.793 97.971
201803 78.922 103.962 99.416
201806 85.266 104.875 106.472
201809 87.088 105.679 107.920
201812 90.257 105.912 111.601
201903 93.897 105.886 116.130
201906 96.443 106.742 118.323
201909 103.086 107.214 125.916
201912 101.116 107.766 122.877
202003 108.709 106.563 133.595
202006 103.656 107.498 126.277
202009 103.293 107.635 125.675
202012 97.875 108.296 118.356
202103 104.795 108.360 126.650
202106 103.042 108.928 123.882
202109 107.976 110.338 128.154
202112 111.070 112.486 129.309
202203 113.899 114.825 129.901
202206 121.569 118.384 134.481
202209 130.692 122.296 139.948
202212 123.798 126.365 128.297
202303 125.115 127.042 128.971
202306 127.002 129.407 128.524
202309 127.362 130.224 128.080
202312 120.157 130.958 120.157
202403 125.164 130.958 125.164

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Probi AB  (OSTO:PROB) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Probi AB Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Probi AB's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Probi AB (OSTO:PROB) Business Description

Industry
Traded in Other Exchanges
Address
Ideongatan 1 A, Lund, SWE, SE-223 70
Probi AB is engaged in probiotic research and development, manufacturing and sales of effective and well-documented probiotics. The company's research relates to living microorganisms with scientific health benefits. The main fields of research are gut health, immune system and nutrient absorption, iron absorption, bone health and stress and recovery. It operates in Consumer Healthcare (CHC) and Functional Food (FF). The company operates in United States, Americas, excluding the United States , Sweden, EMEA, excluding Sweden, and APAC. The company's business is divided into three operating segments. These segments are based on a geographical division and consist of the regions Americas (North and South America), EMEA (Europe, Middle East and Africa) and APAC (Asia and the Pacific).

Probi AB (OSTO:PROB) Headlines

No Headlines